Conditional sentence

CVS Health to Invest $6.5 Million in Affordable Housing in Denver

Retrieved on: 
Friday, January 21, 2022
City, House Place Plantation, CVS Health, Nursing, Disability in Canada, Topical steroid withdrawal, Poverty, Volksgemeinschaft, House, COSC, Population, NYSE, Senior, Colorado Department of Corrections, Bailey House (charity), Charity's House, Physician, Health equity, Clothing, Mental health, CVS, Colorado Department of Local Affairs, Health, Housing, Aetna, Pharmacist, Heart, Food, Metro, Aurora Mental Health Center, Point, Practitioner, Administration, Conditional sentence, Homelessness, Substance abuse, Investment, Public relations, Renewable energy, Medicine

"Our commitment to advancing health equity is grounded in our company purpose to bring our heart to every moment of health," said David Casey, Senior Vice President and Chief Diversity Officer, CVS Health.

Key Points: 
  • "Our commitment to advancing health equity is grounded in our company purpose to bring our heart to every moment of health," said David Casey, Senior Vice President and Chief Diversity Officer, CVS Health.
  • In addition to COSC services, the Mental Health Center of Denver will provide residents with an array of mental health, substance abuse and integrated health services.
  • "CVS Health is committed to providing underserved communities in Denver with opportunities that can help them live healthier lives," said Jim Boyman, North Central Territory President and Heartland Market President, Aetna, a CVS Health company.
  • As part of CVS Health's overall commitment to advance health equity in America, it invested $185 million in affordable housing nationwide in 2021 and $1.3 billion over the past 20 years.

Global $816 Mn Solid-State Cooling Markets to 2026: Focus on Medical, Automotive, Consumer, Semiconductor & Electronics, Research, Industrial, and Aerospace - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Other Manufacturing, Manufacturing, CAGR, Research, Semiconductor, Technology, Health, Competitive analysis, Thermal cycler, Adoption, Global, Temperature, Conditional sentence, Geography, Industry, Greenhouse gas, Heat, COVID-19, Consumer, Lists of Palestinian rocket attacks on Israel, USD, Projection, Internet, Maintenance, Impact, Awareness, Heating, ventilation, and air conditioning, Chiller, Automotive industry, Electronics, Medicine, Aerospace, Refrigerator

The most popular solid-state cooling systems forms are single-stage, multi-stage, and thermocycler.

Key Points: 
  • The most popular solid-state cooling systems forms are single-stage, multi-stage, and thermocycler.
  • The worldwide Solid-State Cooling Market is primarily driven by the rising awareness of energy conservation technologies for heating and cooling for various applications worldwide.
  • Unlike compressor-based conventional cooling systems, solid-state thermoelectric heating and cooling do not require costly Greenhouse Gas refrigerants.
  • However, higher costs than conventional cooling and refrigeration systems will hamper the expansion of Solid-State Cooling throughout the projection period.

Global Ultrasound Device Market (2021 to 2028) - Size, Share & Trends Analysis Report - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Medical Devices, Health, CAGR, Technology, HIFU, ESWL, GE Healthcare, Adoption, Degenerative disease, Health, Artery, Tissue, Extracorporeal shockwave therapy, Asia-Pacific, Diagnosis, Artificial intelligence, Cancer, Neoplasm, Prevalence, Conditional sentence, Medical imaging, Ultrasound

An increase in the adoption of ultrasound devices for diagnosis and treatment is driving the market.

Key Points: 
  • An increase in the adoption of ultrasound devices for diagnosis and treatment is driving the market.
  • In addition, a rise in the adoption of minimally invasive surgeries, coupled with technological advancements, is expected to boost market growth.
  • Hand-held ultrasound devices have made the technology more accessible for use in limited-resource communities around the world.
  • Asia Pacific is anticipated to expand at the fastest CAGR over the forecast period owing to the increased demand for better imaging devices

The Worldwide Omics-Based Clinical Trials Industry is Expected to Reach $49.5 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Health, Clinical Trials, Biomarker, CAGR, COVID-19, Cancer, Research, Technology, Vaccine, Clinical trial, Biotechnology, Genomics, Adoption, Growth, Death, Industry, Proteomics, Ecosystem, Cros, Drug development, Teaching hospital, Omics, Therapy, USD, Toxicity, OMICS, Prevalence, Lists of countries and territories, Metabolomics, Clinical study design, Drug discovery, Conditional sentence, Coronavirus, Medical imaging, Pharmaceutical industry, Fine chemical

The global omics-based clinical trials market size is anticipated to reach USD 49.5 billion by 2030.

Key Points: 
  • The global omics-based clinical trials market size is anticipated to reach USD 49.5 billion by 2030.
  • The outbreak of coronavirus accelerated the adoption of new approaches, models, and technology in clinical trials, this has positively impacted market growth.
  • Initially, the outbreak has negatively impacted the ecosystem of clinical trials and affected many ongoing studies for numerous indications.
  • There has been an increase in the clinical trials activity with oncology trials attaining historically high levels.

Global Single-Chamber Prefilled Syringes Markets Report 2015-2020 & 2021-2030 Featuring Major Players - BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, Terumo - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Diabetes, Health, Medical Supplies, Patient, Diabetes, International Diabetes Federation, BD, Companion, COVID-19, American Cancer Society, Growth, Near-field communication, NFC, Abdul Injai, Cancer, Conditional sentence, Schott AG, Vetter Pharma, Time, Marketing, Prevalence, Organization, Syringe, Borosilicate glass, Pharmaceutical industry, Catalent, Credence

The "Global Single-Chamber Prefilled Syringes Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Single-Chamber Prefilled Syringes Market Report 2021: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering.
  • Major players in the single-chamber prefilled syringes market are BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, and Terumo.
  • The single-chamber prefilled syringes market consists of sales of single-chamber prefilled syringes by entities (organizations, sole traders, and partnerships) that manufacture disposable single-chamber syringes with already loaded liquid medicine to be injected.
  • The companies involved in the single-chamber prefilled syringes market are primarily engaged in the development, manufacturing, and marketing of single-chamber prefilled syringes.

Worldwide Non-emergency Medical Transportation Industry to 2027 - Adoption of Automation in NEMT Services Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Friday, January 21, 2022
Other Transport, Public Transport, Infectious Diseases, Transport, Transportation, Managed Care, Health, General Health, Travel, Product type, Use, Region, CAGR, Customer support, Market share analysis, R, COVID-19, Value, Growth, Degenerative disease, Global, Acquisition, Kidney disease, Strategic management, Commission on Accreditation of Medical Transport Systems, USD, Certification, Cancer, Decision-making, Business Growth Fund, Prevalence, Conditional sentence, Investment, Retail, Transport, Healthcare

What are the inhibiting factors and impact of COVID-19 shaping the Global Non-emergency Medical Transportation Market during the forecast period?

Key Points: 
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Non-emergency Medical Transportation Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Non-emergency Medical Transportation Market?
  • What is the competitive strategic window for opportunities in the Global Non-emergency Medical Transportation Market?
  • What modes and strategic moves are considered suitable for entering the Global Non-emergency Medical Transportation Market?

DGAP-News: BB BIOTECH AG: 2021 was a difficult year for biotech equity markets - increased dividend of CHF 3.85 proposed

Retrieved on: 
Friday, January 21, 2022
Net asset value, Vaccination, Technology, Patient, Vertex, Annual report, Vaccine, Biotechnology, Clinical trial, Bipolar disorder, Swings, RNA, AGM, COVID-19, Board of directors, Severe acute respiratory syndrome coronavirus 2, Blas, Policy, EUA, CEO, NBI, Nasdaq Composite, Industry, BB Biotech, Government, Annual, Executive, Beta thalassemia, Destiny, CRISPR Therapeutics, Therapy, Prognosis, Macrogen, Gene editing, GMG, Environment, SPI, NDAS, Director, NAV, Dow Jones, Blood, FDA, CRISPR, Conditional sentence, Omicron, Annual general meeting, Board, Investment, Fine chemical, Pharmaceutical industry, Bank, Alnylam Pharmaceuticals, Ionis, EUR, CHF, Neurocrine, USD

Media release as at January 21, 2022

Key Points: 
  • Media release as at January 21, 2022
    Portfolio of BB Biotech AG as at December 31, 2021
    The year 2021 was a volatile market environment for all involved in biotechnology investing, including BB Biotech.
  • BB Biotech carefully adjusted the portfolio in the last three months of 2021.
  • The net loss for BB Biotech in 2021 was CHF 405 mn.
  • The highly specialized investment team at BB Biotech believes that the growth case for biotechnology and valuations for portfolio companies are both compelling.

Insights on the Clinical Alarm Management Global Market to 2026 - Featuring Baxter International, Ascom Holding and Spok Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 20, 2022
Technology, Security, People, Ageing, Patient, Cataract, Diabetes, Stroke, LTC, Chronic kidney disease, Dementia, Nihon Kohden, Approximation error, Falls, Population, Safety, Chronic obstructive pulmonary disease, Human, Solution, Health, Center, Alzheimer's disease, Neck pain, Long-term care, Chronic lung disease, Diagnosis, Association, Depression, Conditional sentence, Alzheimer's Association, USD, Statistics, Cancer, Prevalence, Hearing loss, Osteoarthritis, AWARE, Hospital, Systematic review, Health insurance

The necessity for long-term care can arise suddenly, such as after a heart attack or stroke.

Key Points: 
  • The necessity for long-term care can arise suddenly, such as after a heart attack or stroke.
  • As per 2019 research study titled "Alarming and/or Alerting Device Effectiveness in Reducing Falls in Long-Term Care (LTC) Facilities?
  • Growing prevalence of chronic diseases coupled with the increasing geriatric population globally are the major factors driving the respective segment in the market studied.
  • Thus, owing to the aforementioned factors the usage of clinical alarm management solutions and services are expected to grow significantly during the forecast period.

The Worldwide Heparin Industry is Expected to Reach $10 Billion by 2027 - ResearchAndMarkets.com

Retrieved on: 
Thursday, January 20, 2022
Medical Supplies, Health, Hospitals, Other Science, Science, Pharmaceutical, Cardiology, CDC, Heparin, Medicine, Pulmonary embolism, COVID-19, Respiratory disease, Cardiopulmonary bypass, Patient, LMW, Center, Korea Disease Control and Prevention Agency, Hemofiltration, Atomic mass, Infarction, LMWH, Severe acute respiratory syndrome coronavirus 2, Hip, Growth, Atrial fibrillation, Acute coronary syndrome, Skin, Viral disease, Thrombosis, Deep vein thrombosis, UFH, CT, Risk, Blood, Conditional sentence, Pharmaceutical industry

Heparin is widely used as an anticoagulant in medicine that acts as a blood thinner.

Key Points: 
  • Heparin is widely used as an anticoagulant in medicine that acts as a blood thinner.
  • Acute coronary syndrome, pulmonary embolism, atrial fibrillation, deep vein thrombosis, cardiopulmonary bypass & hemofiltration during cardiac surgery can be treated by the use of heparin.
  • The increasing incidences of chronic diseases will positively influence the expansion of the heparin market across the globe.
  • Moreover, the introduction of highly precise and upgraded heparin products by the market players will boost the growth of the heparin market.

Newtopia Engages Stonegate Capital Partners to Drive U.S. Investor Communication Programs

Retrieved on: 
Thursday, January 20, 2022
Forward-looking statement, Research, News, Stroke, Legislation, LinkedIn, Risk, OTCQB, COVID-19, Degenerative disease, Public expenditure, Growth, CEO, Mental health, Toronto Stock Exchange, Good, Awareness, Agreement, Company, TSX Venture Exchange, Conditional sentence, Multimedia, Data science, Contract, Twitter, Terminology, Stonegate, Public relations, Risk management, Facebook

"Newtopia looks forward to partnering with Stonegate to continue to expand our investor communication efforts in the U.S." said Jeff Ruby, Founder and CEO of Newtopia.

Key Points: 
  • "Newtopia looks forward to partnering with Stonegate to continue to expand our investor communication efforts in the U.S." said Jeff Ruby, Founder and CEO of Newtopia.
  • Pursuant to the terms of an advisory services agreement (the "Agreement"), Stonegate will receive a month fee of US$5,000 commencing on January 4, 2022.
  • Newtopia's programs leverage genetic, social and behavioral insights to create individualized prevention programs with a focus on type-2 diabetes, heart disease, stroke and weight.
  • Stonegate Capital Partners will provide investor relations services to the Company with a specific focus on the U.S. small-cap institutional investment community.